Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xianjun Yu

Showing results (291-300 of 421) with videos related to

Pageof 43
Sort By:
Trials|August 17, 2023
Radical antegrade modular pancreatosplenectomy (RAMPS) versus standard retrograde pancreatosplenectomy (SRPS) for resectable body and tail pancreatic adenocarcinoma: protocol of a multicenter, prospective, randomized phase III control trial (CSPAC-3)Jialin Li, Si Shi, Jiang Liu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 8, 2025
ACSL5 Regulates Glucose Metabolism and Chemotherapy Sensitivity in Colorectal Cancer Cells under Glutamine DeficiencyShuai Tian, Qiaoxia Zhang, Xuedan Sun, et al.
Cell Proliferation|April 2, 2019
Homeodomain-interacting protein kinase 2 suppresses proliferation and aerobic glycolysis via ERK/cMyc axis in pancreatic cancerYi Qin, Qiangsheng Hu, Shunrong Ji, et al.
Acta Biochimica Et Biophysica Sinica|October 2, 2021
SETD8 induces stemness and epithelial-mesenchymal transition of pancreatic cancer cells by regulating ROR1 expressionMengqi Liu, Yihua Shi, Qiangsheng Hu, et al.
Frontiers in Oncology|May 17, 2021
RIPK3 Suppresses the Progression of Spontaneous Intestinal TumorigenesisQun Zhao, Jian Guo, Xinran Cheng, et al.
International Journal of Oncology|April 17, 2013
Silencing of MBD1 reverses pancreatic cancer therapy resistance through inhibition of DNA damage repairJin Xu, Wenwei Zhu, Wenyan Xu, et al.
Acta Biochimica Et Biophysica Sinica|October 12, 2018
SNX6 predicts poor prognosis and contributes to the metastasis of pancreatic cancer cells via activating epithelial-mesenchymal transitionPengfei Hu, Yun Liang, Qiangsheng Hu, et al.
Cancer Immunology, Immunotherapy : CII|March 2, 2024
Ectopic CXCR2 expression cells improve the anti-tumor efficiency of CAR-T cells and remodel the immune microenvironment of pancreatic ductal adenocarcinomaZhengjie Dai, Xuan Lin, Xu Wang, et al.
International Journal of Surgery (London, England)|January 27, 2025
Dense stroma activates the TGF-β1/FBW7 axis to induce metabolic subtype switching in pancreatic cancerZeyin Rong, Jianhui Yang, Jiang Liu, et al.
Cell Proliferation|February 27, 2020
Ferroptosis: Final destination for cancer?Zeng Ye, Wensheng Liu, Qifeng Zhuo, et al.
Pageof 43

Showing results (291-300 of 421) with videos related to

Sort By:
Pageof 43
Trials|August 17, 2023
Radical antegrade modular pancreatosplenectomy (RAMPS) versus standard retrograde pancreatosplenectomy (SRPS) for resectable body and tail pancreatic adenocarcinoma: protocol of a multicenter, prospective, randomized phase III control trial (CSPAC-3)Jialin Li, Si Shi, Jiang Liu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 8, 2025
ACSL5 Regulates Glucose Metabolism and Chemotherapy Sensitivity in Colorectal Cancer Cells under Glutamine DeficiencyShuai Tian, Qiaoxia Zhang, Xuedan Sun, et al.
Cell Proliferation|April 2, 2019
Homeodomain-interacting protein kinase 2 suppresses proliferation and aerobic glycolysis via ERK/cMyc axis in pancreatic cancerYi Qin, Qiangsheng Hu, Shunrong Ji, et al.
Acta Biochimica Et Biophysica Sinica|October 2, 2021
SETD8 induces stemness and epithelial-mesenchymal transition of pancreatic cancer cells by regulating ROR1 expressionMengqi Liu, Yihua Shi, Qiangsheng Hu, et al.
Frontiers in Oncology|May 17, 2021
RIPK3 Suppresses the Progression of Spontaneous Intestinal TumorigenesisQun Zhao, Jian Guo, Xinran Cheng, et al.
International Journal of Oncology|April 17, 2013
Silencing of MBD1 reverses pancreatic cancer therapy resistance through inhibition of DNA damage repairJin Xu, Wenwei Zhu, Wenyan Xu, et al.
Acta Biochimica Et Biophysica Sinica|October 12, 2018
SNX6 predicts poor prognosis and contributes to the metastasis of pancreatic cancer cells via activating epithelial-mesenchymal transitionPengfei Hu, Yun Liang, Qiangsheng Hu, et al.
Cancer Immunology, Immunotherapy : CII|March 2, 2024
Ectopic CXCR2 expression cells improve the anti-tumor efficiency of CAR-T cells and remodel the immune microenvironment of pancreatic ductal adenocarcinomaZhengjie Dai, Xuan Lin, Xu Wang, et al.
International Journal of Surgery (London, England)|January 27, 2025
Dense stroma activates the TGF-β1/FBW7 axis to induce metabolic subtype switching in pancreatic cancerZeyin Rong, Jianhui Yang, Jiang Liu, et al.
Cell Proliferation|February 27, 2020
Ferroptosis: Final destination for cancer?Zeng Ye, Wensheng Liu, Qifeng Zhuo, et al.
Pageof 43